| GCST90199705 |
Propionylglycine levels |
Myocardial infarction |
0.007 |
0.323 |
| GCST90199741 |
Gamma-glutamylglycine levels |
Myocardial infarction |
0.006 |
0.282 |
| GCST90199807 |
Hexadecanedioate (C16-DC) levels |
Myocardial infarction |
0.004 |
0.398 |
| GCST90200054 |
1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) levels |
Myocardial infarction |
0.006 |
0.257 |
| GCST90200059 |
Behenoyl dihydrosphingomyelin (d18:0/22:0) levels |
Myocardial infarction |
0.007 |
0.467 |
| GCST90200065 |
1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6) levels |
Myocardial infarction |
0.006 |
0.333 |
| GCST90200259 |
Pentose acid levels |
Myocardial infarction |
0.007 |
0.131 |
| GCST90200438 |
Alpha-ketobutyrate levels |
Myocardial infarction |
0.007 |
0.387 |
| GCST90200630 |
X-24546 levels |
Myocardial infarction |
0.005 |
0.873 |
| GCST90200680 |
5-acetylamino-6-formylamino-3-methyluracil levels |
Myocardial infarction |
0.005 |
0.311 |
| GCST90200707 |
Glycine levels |
Myocardial infarction |
0.003 |
0.206 |
| GCST90200726 |
N-acetylputrescine to (N (1) + N (8))-acetylspermidine ratio |
Myocardial infarction |
0.004 |
0.058 |
| GCST90200758 |
Glycine to serine ratio |
Myocardial infarction |
0.005 |
0.505 |
| GCST90200782 |
Mannose to trans-4-hydroxyproline ratio |
Myocardial infarction |
0.007 |
0.783 |